Is administering 35 units of insulin glargine (Lantus) at bedtime considered standard practice?

No, 35 Units of Lantus at Bedtime is NOT Standard Practice

The standard starting dose of Lantus (insulin glargine) for insulin-naïve patients with type 2 diabetes is 10 units once daily OR 0.1-0.2 units/kg/day, not 35 units 1, 2. A dose of 35 units would only be appropriate after systematic titration based on fasting glucose monitoring, or in specific clinical scenarios requiring higher initial doses.

Standard Initiation Protocol

According to the 2025 ADA Standards of Care and FDA labeling:

• Type 2 diabetes (insulin-naïve): Start with 10 units once daily OR 0.1-0.2 units/kg 1, 2
• Type 1 diabetes: Start with approximately one-third of total daily insulin requirements 2
• Converting from NPH:
  • Once-daily NPH → same dose of Lantus
  • Twice-daily NPH → 80% of total NPH dose 2

When 35 Units Might Be Appropriate

A dose of 35 units would typically only be reached through:

1. Systematic titration: Increase by 2 units every 3 days until fasting plasma glucose reaches target without hypoglycemia 1
2. Weight-based dosing in heavier patients: A 175-200 kg patient using 0.2 units/kg would approach this dose
3. Conversion from high-dose NPH: If previously on 35-44 units of once-daily NPH, or 44-55 units of twice-daily NPH (80% conversion) 2

Critical Safety Considerations

Starting at 35 units without proper titration significantly increases hypoglycemia risk, particularly nocturnal hypoglycemia 1, 2. The FDA label explicitly warns that dose individualization with glucose monitoring is essential 2.

Timing Considerations

While bedtime administration is common, Lantus can be given at any consistent time of day 2. However:

• Bedtime dosing carries higher nocturnal hypoglycemia risk compared to morning dosing 3
• The pharmacodynamic profile shifts based on administration time, though 24-hour coverage remains similar 4

Proper Approach

If a patient is currently on 35 units at bedtime, evaluate:

• How was this dose reached? (titration history vs. arbitrary starting dose)
• Fasting glucose control: Is it at goal without hypoglycemia?
• Hypoglycemia frequency: Particularly overnight episodes
• Signs of overbasalization: Bedtime-to-morning glucose differential >50 mg/dL, high glucose variability 1

If this was started as an initial dose without titration, it should be reduced and properly titrated upward based on glucose monitoring 1, 2.